| Dosage controlled by periodic determination of prothrombin time. Avoid abrupt cessation and discontinue use at the earliest sign of bleeding. Hepatic/Renal disorders, Diabetes mellitus (severe). Elderly patients, Hepatic dysfunction, Renal impairment or other Renal disorders |